Alternative isoforms of RNA polymerase III impact the non-coding RNA transcriptome, viability, proliferation and differentiation of prostate cancer cells

Abstract

RNA polymerase III (pol III) synthesizes short noncoding RNA (ncRNA) exclusively and is unique in having alternative paralogues of one of its subunits, POLR3G and POLR3GL. Although most pol III target loci can be transcribed by either isoform, exceptions have been found. For example, depletion of POLR3G curtails the production of BC200 and snaR ncRNAs that are implicated in cancer progression. Furthermore, POLR3G may protect pol III against repression by MAF1, a key physiological regulator. Expression of POLR3G is promoted selectively by MYC, NANOG and OCT4A, master regulators of stem cell pluripotency, resulting in its preferential accumulation in undifferentiated cells. Indeed, differentiation of prostate cancer cells is suppressed by a positive feedback mechanism between POLR3G and NANOG, involving the control of NANOG mRNA degradation by ncRNAs. Specific knockdown of POLR3G inhibits proliferation and induces differentiation of prostate cancer cells, but this response is not seen following comparable depletion of its POLR3GL paralogue. ML-60218 is a cell-permeable small molecule pol III inhibitor that triggers the replacement of POLR3G with POLR3GL. Proliferation and viability of primary prostate cancer cells are suppressed by ML-60218, whereas differentiation is induced, effects that mimic POLR3G depletion. Transient exposure to ML-60218 reduced tumour initiating activity in a xenograft model. Untransformed prostate cells are much less sensitive to these treatments, raising the possibility of therapeutic benefit.

Keywords

Prostate cancer / POLR3G / SINEs / RNA Polymerase III / MAF1 / ncRNA / NANOG

References

[1] DieciG,CastelnuovoM,PaganoA.The expanding RNA polymerase III transcriptome.Trends Genet2007;23:614-22

[2] HaurieV,Dumay-OdelotH.Two isoforms of human RNA polymerase III with specific functions in cell growth and transformation.Proc Natl Acad Sci U S A2010;107:4176-81 PMCID:PMC2840155

[3] RenaudM,VieuE.Gene duplication and neofunctionalization: POLR3G and POLR3GL.Genome Res2014;24:37-51 PMCID:PMC3875860

[4] Durrieu-GaillardS,BoldinaG.Regulation of RNA polymerase III transcription during transformation of human IMR90 fibroblasts with defined genetic elements.Cell Cycle2018;17:605-15 PMCID:PMC5969553

[5] VanBortle K,LiuQ.A cancer-associated RNA polymerase III identity drives robust transcription and expression of SNAR-A noncoding RNA.bioRxiv2021;

[6] LiuX,WangH,XuK.Increased expression of POLR3G predicts poor prognosis in transitional cell carcinoma.PeerJ2020;8:e10281 PMCID:PMC7646299

[7] KhattarE,LiuCY.Telomerase reverse transcriptase promotes cancer cell proliferation by augmenting tRNA expression.J Clin Invest2016;126:4045-60 PMCID:PMC5096818

[8] WangX,ChenWY.Functions of paralogous RNA polymerase III subunits POLR3G and POLR3GL in mouse development.Proc Natl Acad Sci U S A2020;117:15702-11 PMCID:PMC7355021

[9] WongRC,FongH.A novel role for an RNA polymerase III subunit POLR3G in regulating pluripotency in human embryonic stem cells.Stem Cells2011;29:1517-27

[10] EnverT,JoshiC.Cellular differentiation hierarchies in normal and culture-adapted human embryonic stem cells.Hum Mol Genet2005;14:3129-40

[11] JinS,ZhuL.A novel role for miR-1305 in regulation of pluripotency-differentiation balance, cell cycle, and apoptosis in human pluripotent stem cells.Stem Cells2016;34:2306-17 PMCID:PMC5031214

[12] KaighnME,OhnukiY,JonesLW.Establishment and characterization of a human prostatic carcinoma cell line (PC-3).Invest Urol1979;17:16-23

[13] PetrieJL,IngramRM.Effects on prostate cancer cells of targeting RNA polymerase III.Nucleic Acids Res2019;47:3937-56 PMCID:PMC6486637

[14] WuL,ThoroddsenV.Novel small-molecule inhibitors of RNA polymerase III.Eukaryot Cell2003;2:256-64 PMCID:PMC154847

[15] PaganoA,TortelliF,DieciG.New small nuclear RNA gene-like transcriptional units as sources of regulatory transcripts.PLoS Genet2007;3:e1 PMCID:PMC1790723

[16] ChenCY,WalkeyCJ,LuW.Maf1 and repression of RNA polymerase III-mediated transcription drive adipocyte differentiation.Cell Rep2018;24:1852-64 PMCID:PMC6138453

[17] DeiningerP.Alu elements: know the SINEs.Genome Biol2011;12:236 PMCID:PMC3334610

[18] HuQ,TrabucchiM.DICER- and AGO3-dependent generation of retinoic acid-induced DR2 Alu RNAs regulates human stem cell proliferation.Nat Struct Mol Biol2012;19:1168-75 PMCID:PMC3743530

[19] Morales-HernándezA,RománAC.Alu retrotransposons promote differentiation of human carcinoma cells through the aryl hydrocarbon receptor.Nucleic Acids Res2016;44:4665-83 PMCID:PMC4889919

[20] FisherR,SwantonC.Cancer heterogeneity: implications for targeted therapeutics.Br J Cancer2013;108:479-85 PMCID:PMC3593543

[21] AjaniJA,HochsterHS.Cancer stem cells: the promise and the potential.Semin Oncol2015;42 Suppl 1:S3-17

[22] KresoA.Evolution of the cancer stem cell model.Cell Stem Cell2014;14:275-91

[23] HuY.ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays.J Immunol Methods2009;347:70-8

[24] ParrottAM.Novel rapidly evolving hominid RNAs bind nuclear factor 90 and display tissue-restricted distribution.Nucleic Acids Res2007;35:6249-58 PMCID:PMC2094060

[25] LeeJ,KimWW.Biological function of long noncoding RNA snaR in HER2-positive breast cancer cells.Tumour Biol2017;39:1010428317707374

[26] HuangY,JinZ.LncRNA snaR upregulates GRB2-associated binding protein 2 and promotes proliferation of ovarian carcinoma cells.Biochem Biophys Res Commun2018;503:2028-32

[27] ShiZ,WuH.Long non-coding RNA snaR is involved in the metastasis of liver cancer possibly through TGF-β1.Oncol Lett2019;17:5565-71 PMCID:PMC6507301

[28] ChenW,BrosiusJ.Expression of neural BC200 RNA in human tumours.J Pathol1997;183:345-51

[29] IacoangeliA,MorleyEJ.BC200 RNA in invasive and preinvasive breast cancer.Carcinogenesis2004;25:2125-33

[30] SinghR,PengWX.Regulation of alternative splicing of Bcl-x by BC200 contributes to breast cancer pathogenesis.Cell Death Dis2016;7:e2262 PMCID:PMC5143396

[31] SamsonJ,DeanK.BC200 (BCYRN1) - the shortest, long, non-coding RNA associated with cancer.Noncoding RNA Res2018;3:131-43 PMCID:PMC6114260

[32] MurawskiM,ZoładekT,MartinNC.maf1 mutation alters the subcellular localization of the Mod5 protein in yeast.Acta Biochim Pol1994;41:441-8

[33] PlutaK,MartinNC.Maf1p, a negative effector of RNA polymerase III in Saccharomyces cerevisiae.Mol Cell Biol2001;21:5031-40 PMCID:PMC87229

[34] UpadhyaR,WillisIM.Maf1 is an essential mediator of diverse signals that repress RNA polymerase III transcription.Molecular Cell2002;10:1489-94

[35] CieślaM.Regulation of RNA polymerase III transcription by Maf1 protein.Acta Biochim Pol2008;55:215-25

[36] VorländerMK,MoirRD.Structural basis for RNA polymerase III transcription repression by Maf1.Nat Struct Mol Biol2020;27:229-32 PMCID:PMC7104376

[37] VanniniA,KusserAG,KassavetisGA.Molecular basis of RNA polymerase III transcription repression by Maf1.Cell2010;143:59-70

[38] KantidakisT,BirchJL,WhiteRJ.mTOR associates with TFIIIC, is found at tRNA and 5S rRNA genes, and targets their repressor Maf1.Proc Natl Acad Sci U S A2010;107:11823-8 PMCID:PMC2900655

[39] WoiwodeA,ZhongS.PTEN represses RNA polymerase III-dependent transcription by targeting the TFIIIB complex.Mol Cell Biol2008;28:4204-14 PMCID:PMC2423115

[40] GirbigM,VorländerMK.Cryo-EM structures of human RNA polymerase III in its unbound and transcribing states.Nat Struct Mol Biol2021;28:210-9 PMCID:PMC7610652

[41] TerryS.The many faces of neuroendocrine differentiation in prostate cancer progression.Front Oncol2014;4:60 PMCID:PMC3971158